the role of dna repair in triple negative breast cancer
Published 7 years ago • 190 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:02
dr. mark robson on how dna-damaging agents function in treating breast cancer
-
3:50
clinical approach to triple-negative breast cancer
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
3:05
dna damage response inhibitors in breast cancer
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:31
dr. bhalla on dna-damaging agents in breast cancer
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
1:40
treatment of metastatic triple-negative breast cancer
-
1:00
overcoming challenges in treating patients with triple-negative breast cancer
-
1:10
comparing 3 types of targeted therapies for triple-negative breast cancer
-
22:54
testing, treating, and targeting triple negative breast cancer | 2023 west oncology conference
-
21:41
ms1 targeting dna damage response and hrd in breast cancer timothy a. yap
-
3:00
eribulin’s role in triple-negative breast cancer
-
0:48
dr. william sikov on triple-negative breast cancer patients not responding to treatment
-
5:38
case 4: olympiad trial for brca metastatic tnbc
-
1:13
crosstalk between triple negative breast cancer and microenvironment | oncotarget
-
5:54
case 3: treatment after progression in triple-negative breast cancer
-
3:37
case 3: pd-l1 testing used in triple-negative breast cancer
-
8:19
circulating tumour dna used to predict disease recurrence for early triple-negative breast cancer